stockrowPrestige Consumer Healthcare Inc.
PBH Healthcare Drug Manufacturers Specialty & Generic
Prestige Consumer Healthcare Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 billion, down 4.31% from fiscal 2025.
- Revenue
- +22.7%
- EPS
- −38.4%
- Free cash flow
- −38.2%
- Total debt
- +100.9%
Quarter to September 2026, against a year earlier
Follow PBH
Alert me
Prestige Consumer Healthcare Inc. (PBH) Total debt
Prestige Consumer Healthcare Inc.'s total debt at the end of fiscal 2026 was $1.0B, unchanged from fiscal 2025. At the end of the quarter to 30 June 2026 it was $2.0B. Over the past ten years it has ranged from $1.0B (fiscal 2026) to $2.2B (fiscal 2017) — the current reading is the lowest in ten years. Prestige Consumer Healthcare Inc. ranks 8th of 84 Drug Manufacturers Specialty & Generic companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2026 | $1.0B | (0.10%) |
| FY2025 | $1.0B | (10.04%) |
| FY2024 | $1.1B | (16.44%) |
| FY2023 | $1.3B | (9.03%) |
| FY2022 | $1.5B | (0.36%) |
| FY2021 | $1.5B | (14.32%) |
| FY2020 | $1.7B | (3.54%) |
| FY2019 | $1.8B | (9.75%) |
| FY2018 | $2.0B | (9.15%) |
| FY2017 | $2.2B | 34.97% |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $2.0B | 101.10% |
| Mar 2026 | $1.0B | (3.83%) |
| Dec 2025 | $1.1B | 3.92% |
| Sep 2025 | $1.0B | (0.03%) |
| 42 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| PRGO Perrigo Company plc compare | $3.3B |
| PBH Prestige Consumer Healthcare Inc. | $2.0B |
| ALVO Alvotech compare | $1.3B |
| BCRX BioCryst Pharmaceuticals, Inc. compare | $839.4M |
| TRLV Trulieve Cannabis Corp. compare | $345.0M |
| XERS Xeris Biopharma Holdings, Inc. compare | $189.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | $94.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | $1.4M |
| RGC Regencell Bioscience Holdings Limited compare | $463.7K |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on PBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement